Tags Artificial Intelligence
Related Insights
Tue 30 Jul 2024
The Secret Life of Sildenafil (Viagra) revealed by AI
White Paper: Sapian AI unveils potential novel biological mechanisms of a wonder drug
Thu 11 Jul 2024
Recap of Rexpo 2024 on AI and Repurposing
Kantify's work on AI for target and drug prediction for rare diseases highlighted at Rexpo2024
Thu 17 Aug 2023
AI and Drug Repurposing: Farewell, serendipity?
Our pledge to make therapies available for patients, faster, and why Artificial Intelligence is the key for small molecule repurposing
Fri 29 Apr 2022
ADMET prediction with Artificial Intelligence : Publication
Peer reviewed publication "Dual Blockade of Misfolded Alpha-Sarcoglycan Degradation by Bortezomib and Givinostat Combination"
Wed 22 Sep 2021
Detecting heart failure with AI: HeartKinetics and Kantify
Collaboration between Kantify and HeartKinetics around real-time detection and classification of heart failure
Thu 12 Aug 2021
AI for Breast Cancer Detection using whole-slide images
Step-by-step approach from data selection, cleaning and augmentation to training of a deep neural network for segmenting whole-slide images and counting nuclei.
Thu 17 Jun 2021
Diagnosing Endometrial Diseases from Tissue Images using AI
Discover how Artificial Intelligence can help diagnose endometrial diseases from tissue images
Thu 27 May 2021
Key AI Techniques in small molecule screening
Discover the key Artificial Intelligence techniques used for small molecule screening
Thu 15 Apr 2021
Draft EU regulation on AI and its impact on healthcare
We share an overview of the new concepts of the draft Regulation on a European Approach For Artificial Intelligence and the impact on AI based medical devices.
Related News
Thu 22 Aug 2024
DREAMS: when AI finds drugs for rare diseases
Discover on the DREAMS project website how Kantify contributes to the discovery of therapeutic targets and treatments for 5 rare neuromuscular disorders
Tue 30 Jul 2024
AI unveils secret targets of drugs, starting with Viagra
In a new White Paper, Kantify presents its AI powered Drug Atlas and unveils the predicted targets for Sildenafil (Viagra)
Wed 24 Jul 2024
A new name for the Kantify AI platform for drug discovery
Kantify shares the new name for its AI platform for small molecule and target discovery
Tue 30 Apr 2024
New poster on AI for drug discovery for muscular dystrophies
At Myology 2024, Emilie PELLIER & Quentin MIAGOUX from i-Stem presented our collaboration on AI powered target and drug discovery for LGMDR2
Tue 02 Apr 2024
Kantify reveals promising results in sarcoma at ESMO
Kantify Unveiled Promising Results in Liposarcoma Drug Discovery thanks to AI at ESMO Sarcoma and Rare Cancer Congress 2024
Tue 19 Mar 2024
Nicolas Maignan appointed Chief Operating Officer of Kantify
Announcement: Nicolas Maignan is officially appointed COO of Kantify
Thu 14 Mar 2024
AI for Healthcare panel at the Pharma.be General Assembly
Kantify was invited at the pharma.be special panel on AI for Healthcare
Mon 11 Dec 2023
Kantify at Belgium's Biopharmaceutical Excellence Conference
Kantify shared some of its groundbreaking work at the Conference on the Belgian biopharmaceutical sector organized by the Federal Ministry of Foreign Affairs
Thu 07 Dec 2023
Appointment of Dr Eckhard von Keutz as Scientific Advisor
Kantify appoints Dr von Keutz, former Vice-President at Bayer Pharmaceuticals, as Scientific Advisor
Wed 29 Nov 2023
Kantify will use its AI platform to tackle 5 rare diseases
Kantify is selected by the European Commission to perform an unprecedented research project on rare diseases and AI
Thu 05 Oct 2023
Kantify speaking at Slush'D Leuven
Kantify will be speaking in the panel on "AI: redefining business or enhancing roles"
Thu 15 Jun 2023
Presentation at Cafes de L'Innovation
Kantify is invited to present its work on AI for target identification and small molecule prediction at Institut Bordet
Tue 06 Jun 2023
Kantify Nominated as Early Startup to Watch by Sifted
We are featured in Sifted's report "AI-Driven Drug Discovery 2.0" Market Report
Mon 22 May 2023
Pitch and Meet at the Tech.eu Summit
Kantify has been selecting to pitch at the Tech.eu Summit 2023 and will present Sapian, its solution for AI powered small molecule discovery
Fri 10 Mar 2023
Portrait in BECI Magazine, Brussels Business
In the March Edition of Brussels Business, a 2 page portrait is dedicated to our CEO and our team
Fri 03 Mar 2023
Upcoming talk: in silico drug discovery and animal testing
Kantify will present at the upcoming study "Animals and Alternatives: The Way Forward"
Tue 28 Feb 2023
When AI meets Stem Cells: spotlight on our work with I-Stem
Kantify and I-Stem work together for faster rare disease drug discovery
Mon 06 Feb 2023
Special edition on Artificial Intelligence in La Libre Eco
Kantify in the special edition of La Libre Eco on Artificial Intelligence
Sun 05 Feb 2023
Kantify' CEO interview on TV LN24
Kantify's CEO was invited as "CEO of the week" by Bruno Wattenbergh on LN24
Thu 27 Oct 2022
Belgian AI Strategy: Kantify joins State Secretary
State Secretary Mathieu Michel invited us to illustrate the power of AI in Health at UCB for the launch event of the Belgian AI plan
Mon 17 Oct 2022
Kantify & Mcule harness data to accelerate drug discovery
Kantify, using its AI technology for drug discovery and Mcule,with its compound sourcing platform, are collaborating to leverage data for better hit prediction
Tue 09 Aug 2022
Kantify in BX1 show on startups and Artificial Intelligence
Kantify was invited to the special edition of BX-1's Startup Story on Start-Ups and Artificial Intelligence
Wed 20 Jul 2022
Fragile X Syndrome: Innovative Approaches to Finding a Cure
Join the talk of our CTO at this cornerstone online event of the Fragile-X patient and research communityt
Mon 02 May 2022
Register to our webinar : Targeted Protein Degraders and AI
Discover how Artificial Intelligence can be used in the discovery and design of Targeted Protein Degraders.
Wed 27 Apr 2022
New discovery with I-Stem (Press Release)
Announcement : Kantify And I-Stem use Artificial Intelligence (AI) and Stem Cells to Discover A Promising Therapy Against A Rare Disease
Tue 19 Apr 2022
Pediatric acute lymphoblastic leukemia: New collaboration
In partnership with the Lyon University Hospital, Kantify is launching a project using Artificial Intelligence to identify leukemia cells (ALL)
Mon 28 Mar 2022
Kantify at the annual event of Brussels' Healthtech cluster
Kantify is speaking at the annual event of the Brussels cluster of healthtech companies
Tue 22 Mar 2022
Unveiling Sapian, Kantify’s AI drug discovery technology
Discover the new AI technology that accelerates small molecule and targeted protein degradation discovery
Tue 15 Mar 2022
Kantify at the EU AI Week : #breakthebias
Kantify will be represented at the EU AI week event #breakthebias
Tue 23 Nov 2021
Kantify will host a webinar on AI and cardiology in practice
As a part of the webinar series on AI & Health, Kantify will host its next webinar titled AI in cardiology: detection and prediction of pathologies
Wed 17 Nov 2021
Meet us at Science for Health 2021
Kantify as an exhibitor on this year’s Science for Health event lead by flanders.bio
Wed 01 Sep 2021
Kantify at the European Biotech Week: AI for Drug Discovery
Kantify is hosting a virtual event during European Biotech Week titled: Artificial Intelligence in drug discovery and development
Mon 10 May 2021
Kantify joins Data-driven Advanced Therapeutics Accelerator
Kantify joins Data-driven Advanced Therapeutics Accelerator managed by Stevenage Bioscience Catalyst
Wed 14 Apr 2021
The CEO of Kantify interviews with DataNews
The CEO of Kantify speaks about her journey in AI and the potential of AI in the healthcare industry
Tue 16 Mar 2021
Kantify at the Belgian AI Week 2021
Kantify is taking part in several events on Artificial Intelligence (AI) during the 2021 Belgian AI Week.
Thu 05 Nov 2020
Meet us at Medfit 2020
Our CEO is invited as a speaker at Medfit 2020
Wed 28 Oct 2020
Kantify named as Brussels’ AI success story
Kantify was named as Brussels’ Artificial Intelligence success story by hub.brussels